Your browser doesn't support javascript.
loading
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors.
de Glas, Nienke A; Bastiaannet, Esther; van den Bos, Frederiek; Mooijaart, Simon P; van der Veldt, Astrid A M; Suijkerbuijk, Karlijn P M; Aarts, Maureen J B; van den Berkmortel, Franchette W P J; Blank, Christian U; Boers-Sonderen, Marye J; van den Eertwegh, Alfonsus J M; de Groot, Jan-Willem B; Haanen, John B A G; Hospers, Geke A P; Jalving, Hilde; Piersma, Djura; van Rijn, Rozemarijn S; Ten Tije, Albert J; Vreugdenhil, Gerard; Wouters, Michel W J M; Portielje, Johanneke E A; Kapiteijn, Ellen W.
Afiliação
  • de Glas NA; Department of Medical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Bastiaannet E; Department of Medical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • van den Bos F; Department of Surgery, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Mooijaart SP; Department of Gerontology and Geriatrics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • van der Veldt AAM; Department of Gerontology and Geriatrics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
  • Suijkerbuijk KPM; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
  • Aarts MJB; Department of Medical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
  • van den Berkmortel FWPJ; Department of Medical Oncology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
  • Blank CU; Department of Medical Oncology, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands.
  • Boers-Sonderen MJ; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
  • van den Eertwegh AJM; Department of Medical Oncology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • de Groot JB; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Haanen JBAG; Isala Oncology Center, 8025 AB Zwolle, The Netherlands.
  • Hospers GAP; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, 1066 CX Amsterdam, The Netherlands.
  • Jalving H; Department of Medical Oncology, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands.
  • Piersma D; Department of Medical Oncology, University Medical Center Groningen, 9413 GZ Groningen, The Netherlands.
  • van Rijn RS; Department of Medical Oncology, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands.
  • Ten Tije AJ; Department of Medical Oncology, University Medical Center Groningen, 9413 GZ Groningen, The Netherlands.
  • Vreugdenhil G; Department of Medical Oncology, Zuyderland Medical Center, 6162 BG Sittard-Geleen, The Netherlands.
  • Wouters MWJM; Department of Medical Oncology, Medisch Spectrum Twente, 7512 KZ Enschede, The Netherlands.
  • Portielje JEA; Department of Medical Oncology, Medical Center Leeuwarden, 8934 AD Leeuwarden, The Netherlands.
  • Kapiteijn EW; Department of Medical Oncology, Amphia Ziekenhuis, 4818 CK Breda, The Netherlands.
Cancers (Basel) ; 13(11)2021 Jun 05.
Article em En | MEDLINE | ID: mdl-34198950
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article